Multifunctional roles of human cathelicidin (LL-37) at the ocular surface

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 6, 2006, Pages 2369-2380

  Huang, Ling C ^a   Petkova, Tihomira D ^a   Reins, Rose Y ^a   Proske, Rita J ^a   McDermott, Alison M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; EPIDERMAL GROWTH FACTOR RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CYTOKINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; UPREGULATION; WOUND HEALING; ADULT; AGED; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOBLOTTING; LACRIMAL FLUID; MALE; MULTIGENE FAMILY; PHYSIOLOGY;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM, CORNEAL; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MULTIGENE FAMILY; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TEARS; WOUND HEALING;

EID: 33745674745     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1649     Document Type: Article

References (69)

1. Sack RA, Nunes I, Beaton A, et al. Host-defense mechanism of the ocular surfaces. Biosci Rep. 2001;21:463-480.
2. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surface. 2004;2:229-247.
3. Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers. 2000;55:31-49.
4. Lehrer RI, Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol. 2002;9:18-22.
5. Agerberth B, Gunne H, Odeberg J, et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA. 1995;92:195-199.
6. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/probactenecin- like protein of human neutrophil specific granules. FEBS Lett. 1995;368:173-176.
7. Gudmundsson GH, Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods. 1999;232:45-54.
8. Bals R, Wang X, Zasloff M, et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA. 1998;95:9541-9546.
9. Frohm Nilsson M, Sandstedt B, et al. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun. 1999;67:2561-2566.
10. Hase K, Eckmann L, Leopard JD, et al. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun. 2002;70:953-963.
11. Murakami M, Ohtake T, Dorschner RA, et al. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res. 2002;81:845-850.
12. Kim ST, Cha HE, Kim DY, et al. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol. 2003;123:81-85.
13. Hase K, Murakami M, Iimura M, et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology. 2003;125:1613-1625.
14. Travis SM, Anderson NN, Forsyth WR, et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun. 2000;68:2748-2755.
15. Gordon YJ, Huang LC, Romanowski EG, et al. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res. 2005;30:385-394.
16. Tanaka D, Miyasaki KT, Lehrer RI. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol. 2000;15:226-231.
17. De Y, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192:1069-1074.
18. Niyonsaba F, Iwabuchi K, Someya A, et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology. 2002;106:20-26.
19. Niyonsaba F, Someya A, Hirata M, et al. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol. 2001;31:1066-1075.
20. Scott MG, Davidson DJ, Gold MR, et al. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol. 2002;169:3883-3891.
21. Tjabringa GS, Aarbiou J, Ninaber DK, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol. 2003;171:6690-6696.
22. Braff MH, Hawkins MA, Nardo AD, et al. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol. 2005;174:4271-4278.
23. Elssner A, Duncan M, Gavrilin M, et al. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol. 2004;172:4987-4994.
24. Heilborn JD, Nilsson MF, Kratz G, et al. The cathelicidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol. 2003;120:379-389.
25. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111:1665-1672.
26. Shaykhiev R, Beisswenger C, Kandler K, et al. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol. 2005;289:L842-L848.
27. McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci. 2005;46:1379-1385.
28. McDermott AM, Redfern RL, Zhang B. Human β-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr Eye Res. 2001;22:64-67.
29. Foreman DM, Pancholi S, Jarvis-Evans J, et al. A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res. 1996;62:555-564.
30. McDermott AM, Redfern RL, Zhang B, et al. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:1859-1865.
31. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
32. Raff T, van der Giet M, Endemann D, et al. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques. 1997;23:456-460.
33. Paulsen FP, Pufe T, Schaudig U, et al. Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci. 2001;42:2157-2163.
34. O'Callaghan RJ, Engel LS, Hobden JA, et al. Pseudomonas keratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci. 1996;37:534-543.
35. Hobden JA, Masinick SA, Barrett RP, et al. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1107-1114.
36. Gupta A, Heigle T, Pflugfelder SC. Nasolacrimal stimulation of aqueous tear production. Cornea. 1997;16:645-648.
37. Tomita T, Hitomi S, Nagase T, et al. Effect of ions on antibacterial activity of human beta defensin 2. Microbiol Immunol. 2000;44:749-754.
38. Frohm M, Agerberth B, Ahangari G, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem. 1997;272:15258-15263.
39. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151-1160.
40. Erdag G, Morgan JR. Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg. 2002;235:113-124.
41. Becker J, Salla S, Dohmen U, et al. Explorative study of interleukin levels in the human cornea. Graefes Arch Clin Exp Ophthalmol. 1995;233:766-771.
42. Sotozono C, He J, Matsumoto Y, et al. Cytokine expression in the alkali-burned cornea. Curr Eye Res. 1997;16:670-676.
43. Planck SR, Rich LF, Ansel JC, et al. Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea. Ocul Immunol Inflamm. 1997;5:95-100.
44. van 't Hof W, Veerman EC, Helmerhorst EJ, et al. Antimicrobial peptides: properties and applicability. Biol Chem. 2001;382:597-619.
45. Turner J, Cho Y, Dinh NN, et al. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998;42:2206-2214.
46. Bals R, Weiner DJ, Meegalla RL, et al. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest. 1999;103:1113-1117.
47. Schaller-Bals S, Schulze A, Bals R. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med. 2002;165:992-995.
48. Braff MH, Di Nardo A, Gallo RL. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol. 2005;124:394-400.
49. Sorensen O, Arnljots K, Cowland JB, et al. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood. 1997;90:2796-2803.
50. Johansson J, Gudmundsson GH, Rottenberg ME, et al. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem. 1998;273:3718-3724.
51. Nagaoka I, Hirota S, Yomogida S, et al. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res. 2000;49:73-79.
52. Singh PK, Tack BF, McCray PB Jr, et al. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol. 2000;279:L799-L805.
53. Chen X, Niyonsaba F, Ushio H, et al. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci. 2005;40:123-132.
54. Bowdish DM, Davidson DJ, Speert DP, et al. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol. 2004;172:3758-3765.
55. Bals R, Wilson JM. Cathelicidins: a family of multifunctional antimicrobial peptides. Cell Mol Life Sci. 2003;60:711-720.
56. Niyonsaba F, Ushio H, Nagaoka I, et al. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol. 2005;175:1776-1784.
57. Boisjoly HM, Laplante C, Bernatchez SF, et al. Effects of EGF, IL-1 and their combination on in vitro corneal epithelial wound closure and cell chemotaxis. Exp Eye Res. 1993;57:293-300.
58. Sotozono C, Kinoshita S. Growth factors and cytokines in corneal wound healing. In: Nishida T, ed. Corneal Healing Response to Injuries and Refractive Surgeries. The Hague: Kugler Publications; 1998:29-40.
59. Tokumaru S, Sayama K, Shirakata Y, et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol. 2005;175:4662-4668.
60. Lau YE, Rozek A, Scott MG, et al. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun. 2005;73:583-591.
61. Gronert K, Maheshwari N, Khan N, et al. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280:15267-15278.
62. Liu Z, Carvajal M, Carraway CA, et al. Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia. Cornea. 2001;20:81-85.
63. Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756-1765.
64. Wilson SE, Schultz GS, Chegini N, et al. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-71.
65. Xu KP, Ding Y, Ling J, et al. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:813-820.
66. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888.
67. Yan Y, Shirakabe K, Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol. 2002;158:221-226.
68. Smith PC, Santibanez JF, Morales JP, et al. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts: possible modulation by genistein and curcumin. J Periodontal Res. 2004;39:380-387.
69. Amir-Zaltsman Y, Mazor O, Gayer B, et al. Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence. Luminescence. 2000;15:377-380.